Author
Listed:
- Margaux Sevin
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer)
- Lucia Kubovcakova
(University Hospital Basel)
- Nicolas Pernet
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer)
- Sébastien Causse
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer)
- Franck Vitte
(Cypath)
- Jean Luc Villeval
(Gustave Roussy
Laboratory of Excellence GR-Ex)
- Catherine Lacout
(Gustave Roussy
Laboratory of Excellence GR-Ex)
- Marine Cordonnier
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer)
- Fernando Rodrigues-Lima
(CNRS UMR 8251)
- Gaétan Chanteloup
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer)
- Matthieu Mosca
(Gustave Roussy
Laboratory of Excellence GR-Ex)
- Marie-Lorraine Chrétien
(Hospital University Center (CHU))
- Jean Noël Bastie
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer
Hospital University Center (CHU))
- Sylvain Audia
(Hospital University Center (CHU))
- Paul Sagot
(Hospital University Center (CHU))
- Selim Ramla
(Hospital University Center (CHU))
- Laurent Martin
(Hospital University Center (CHU))
- Martin Gleave
(University of British Columbia)
- Valérie Mezger
(UMR7216 Épigénétique et Destin Cellulaire
Sorbonne Paris Cité
Département Hospitalo-Universitaire DHU PROTECT)
- Radek Skoda
(University Hospital Basel)
- Isabelle Plo
(Gustave Roussy
Laboratory of Excellence GR-Ex)
- Carmen Garrido
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer
Centre Georges François Leclerc (CGFL)
LipSTIC LabEx)
- François Girodon
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer
Hospital University Center (CHU))
- Aurélie Thonel
(University of Bourgogne Franche-Comté
UMR 1231, Laboratory of Excellence Ligue National contre le Cancer
UMR7216 Épigénétique et Destin Cellulaire
Sorbonne Paris Cité)
Abstract
Heat shock protein 27 (HSP27/HSPB1) is a stress-inducible chaperone that facilitates cancer development by its proliferative and anti-apoptotic functions. The OGX-427 antisense oligonucleotide against HSP27 has been reported to be beneficial against idiopathic pulmonary fibrosis. Here we show that OGX-427 is effective in two murine models of thrombopoietin- and JAKV617F-induced myelofibrosis. OGX-427 limits disease progression and is associated with a reduction in spleen weight, in megakaryocyte expansion and, for the JAKV617F model, in fibrosis. HSP27 regulates the proliferation of JAK2V617F-positive cells and interacts directly with JAK2/STAT5. We also show that its expression is increased in both CD34+ circulating progenitors and in the serum of patients with JAK2-dependent myeloproliferative neoplasms with fibrosis. Our data suggest that HSP27 plays a key role in the pathophysiology of myelofibrosis and represents a new potential therapeutic target for patients with myeloproliferative neoplasms.
Suggested Citation
Margaux Sevin & Lucia Kubovcakova & Nicolas Pernet & Sébastien Causse & Franck Vitte & Jean Luc Villeval & Catherine Lacout & Marine Cordonnier & Fernando Rodrigues-Lima & Gaétan Chanteloup & Matthieu, 2018.
"HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis,"
Nature Communications, Nature, vol. 9(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03627-9
DOI: 10.1038/s41467-018-03627-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03627-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.